Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Wellgistics Health (WGRX) Invested Capital (2023 - 2025)

Wellgistics Health filings provide 3 years of Invested Capital readings, the most recent being -$1.6 million for Q4 2025.

  • On a quarterly basis, Invested Capital fell 108.36% to -$1.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$1.6 million, a 108.36% decrease, with the full-year FY2025 number at -$1.6 million, down 108.36% from a year prior.
  • Invested Capital hit -$1.6 million in Q4 2025 for Wellgistics Health, down from $19.0 million in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $22.2 million in Q1 2025 to a low of -$3.1 million in Q2 2024.
  • Median Invested Capital over the past 3 years was $10.1 million (2024), compared with a mean of $8.2 million.
  • The widest YoY moves for Invested Capital: up 843.77% in 2025, down 108.36% in 2025.
  • Wellgistics Health's Invested Capital stood at -$2.9 million in 2023, then skyrocketed by 743.43% to $18.7 million in 2024, then plummeted by 108.36% to -$1.6 million in 2025.
  • The last three reported values for Invested Capital were -$1.6 million (Q4 2025), $19.0 million (Q3 2025), and $14.1 million (Q2 2025) per Business Quant data.